I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 6 studies | 26% ± 6% | |
| GABAergic neuron | 5 studies | 33% ± 17% | |
| glutamatergic neuron | 4 studies | 44% ± 28% | |
| ciliated cell | 3 studies | 30% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| oligodendrocyte | 6 studies | 26% ± 6% | |
| GABAergic neuron | 5 studies | 33% ± 17% | |
| glutamatergic neuron | 4 studies | 44% ± 28% | |
| ciliated cell | 3 studies | 30% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 53% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 4672.74 | 2626 / 2642 | 95% | 9.79 | 669 / 705 |
| esophagus | 96% | 2517.18 | 1383 / 1445 | 80% | 6.11 | 147 / 183 |
| lung | 96% | 2115.75 | 556 / 578 | 72% | 5.45 | 837 / 1155 |
| stomach | 90% | 1285.22 | 324 / 359 | 67% | 4.03 | 193 / 286 |
| pancreas | 89% | 1008.88 | 291 / 328 | 68% | 2.25 | 121 / 178 |
| intestine | 88% | 1699.66 | 853 / 966 | 65% | 3.62 | 341 / 527 |
| thymus | 91% | 1327.62 | 592 / 653 | 48% | 1.13 | 292 / 605 |
| kidney | 74% | 821.40 | 66 / 89 | 60% | 2.55 | 540 / 901 |
| liver | 76% | 739.13 | 172 / 226 | 55% | 1.89 | 222 / 406 |
| prostate | 57% | 529.66 | 140 / 245 | 63% | 1.49 | 318 / 502 |
| bladder | 81% | 1259.19 | 17 / 21 | 38% | 1.86 | 191 / 504 |
| skin | 71% | 1385.48 | 1280 / 1809 | 36% | 1.17 | 171 / 472 |
| ovary | 57% | 473.73 | 103 / 180 | 41% | 1.29 | 177 / 430 |
| breast | 50% | 475.13 | 228 / 459 | 47% | 1.76 | 527 / 1118 |
| uterus | 52% | 555.06 | 88 / 170 | 43% | 1.75 | 198 / 459 |
| heart | 94% | 2415.24 | 808 / 861 | 0% | 0 | 0 / 0 |
| spleen | 90% | 1470.26 | 218 / 241 | 0% | 0 | 0 / 0 |
| adrenal gland | 19% | 147.48 | 48 / 258 | 71% | 5.82 | 163 / 230 |
| blood vessel | 61% | 625.91 | 810 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 57% | 2.05 | 46 / 80 |
| muscle | 48% | 411.38 | 387 / 803 | 0% | 0 | 0 / 0 |
| adipose | 44% | 474.04 | 530 / 1204 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 42% | 1.85 | 19 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 3% | 0.12 | 1 / 29 |
| peripheral blood | 1% | 4.89 | 6 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0018230 | Biological process | peptidyl-L-cysteine S-palmitoylation |
| GO_0006612 | Biological process | protein targeting to membrane |
| GO_0005783 | Cellular component | endoplasmic reticulum |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0016020 | Cellular component | membrane |
| GO_0019706 | Molecular function | protein-cysteine S-palmitoyltransferase activity |
| Gene name | ZDHHC11B |
| Protein name | Zinc finger DHHC-type containing 11B Palmitoyltransferase (EC 2.3.1.225) Probable palmitoyltransferase ZDHHC11B (EC 2.3.1.225) (Zinc finger DHHC domain-containing protein 11B) (DHHC-11B) |
| Synonyms | |
| Description | FUNCTION: Probable palmitoyltransferase that could catalyze the addition of palmitate onto various protein substrates and be involved in a variety of cellular processes (By similarity). May play a role in cell proliferation . . |
| Accessions | ENST00000508859.8 A0A7P0TA36 ENST00000522356.3 A0A494BZX9 ENST00000652055.1 ENST00000651083.1 A0A494C0T6 A0A494C1T0 P0C7U3 ENST00000651714.1 |
